Escitalopram versus other antidepressive agents for depression
Escitalopram edged out its parent drug citalopram in head-to-head trials - is there a cost or coverage reason to choose one over the other in my case?
Top of the evidence hierarchy, independently funded. how we score evidence
Caveat on this rating: Most included trials were manufacturer-sponsored comparisons of escitalopram against rival drugs, a known source of sponsorship bias the review discusses.
Pooling 22 randomised trials (about 4,000 people), escitalopram was modestly more effective than citalopram and fluoxetine, and fewer people stopped it than stopped duloxetine.
Worth asking
Escitalopram edged out its parent drug citalopram in head-to-head trials - is there a cost or coverage reason to choose one over the other in my case?
What it is FDA approved for
Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.
- Major depressive disorder (adults and pediatric patients 12 years and older)
- Generalized anxiety disorder (adults and pediatric patients 7 years and older)
Source
Escitalopram versus other antidepressive agents for depression — Cipriani A, et al. (2009)
Top-tier peer-reviewed journal
Read the source: https://doi.org/10.1002/14651858.CD006532.pub2
DOI: 10.1002/14651858.CD006532.pub2
How this was scored
- Study design
- Meta-analysis of randomised trials
- Funding
- No external funding
- Published in
- Top-tier peer-reviewed journal
- Sample size
- 4,000
- Preregistered
- Yes
- Conflicts disclosed
- Yes
- Independent of proponent
- Yes
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "gold standard". Top of the evidence hierarchy, independently funded. It scores 98 out of 100 on our published rubric. One caveat travels with that badge: Most included trials were manufacturer-sponsored comparisons of escitalopram against rival drugs, a known source of sponsorship bias the review discusses. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Escitalopram versus other antidepressive agents for depression — Cipriani A, et al. (2009). Published in: Top-tier peer-reviewed journal. DOI: 10.1002/14651858.CD006532.pub2. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Meta-analysis of randomised trials. Funding: No external funding. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is escitalopram (Lexapro, Cipralex), lexapro, cipralex FDA approved?
Yes — FDA approved for Major depressive disorder (adults and pediatric patients 12 years and older), Generalized anxiety disorder (adults and pediatric patients 7 years and older). Approval is for a specific indication, not for everything the drug is prescribed for.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.